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Coxiella burnetii, a gram-negative obligate intracellular bacterium, causes human Q fever and is considered
a potential agent of bioterrorism. Distinct genomic groups of C. burnetii are revealed by restriction fragment-
length polymorphisms (RFLP). Here we comprehensively define the genetic diversity of C. burnetii by hybrid-
izing the genomes of 20 RFLP-grouped and four ungrouped isolates from disparate sources to a high-density
custom Affymetrix GeneChip containing all open reading frames (ORFs) of the Nine Mile phase I (NMI)
reference isolate. We confirmed the relatedness of RFLP-grouped isolates and showed that two ungrouped
isolates represent distinct genomic groups. Isolates contained up to 20 genomic polymorphisms consisting of
1 to 18 ORFs each. These were mostly complete ORF deletions, although partial deletions, point mutations,
and insertions were also identified. A total of 139 chromosomal and plasmid ORFs were polymorphic among
all C. burnetii isolates, representing ca. 7% of the NMI coding capacity. Approximately 67% of all deleted ORFs
were hypothetical, while 9% were annotated in NMI as nonfunctional (e.g., frameshifted). The remaining
deleted ORFs were associated with diverse cellular functions. The only deletions associated with isogenic NMI
variants of attenuated virulence were previously described large deletions containing genes involved in lipo-
polysaccharide (LPS) biosynthesis, suggesting that these polymorphisms alone are responsible for the lower
virulence of these variants. Interestingly, a variant of the Australia QD isolate producing truncated LPS had
no detectable deletions, indicating LPS truncation can occur via small genetic changes. Our results provide
new insight into the genetic diversity and virulence potential of Coxiella species.
Coxiella burnetii, a gram-negative obligate intracellular bac-
terium, is the etiological agent of human Q fever. Q fever can
manifest as an acute or chronic illness. Acute disease is typi-
cally a self-limiting febrile illness during which pneumonia or
hepatitis can occur (41). Chronic disease, although rare, is a
severe illness that usually manifests as endocarditis and occa-
sionally as vascular infection, osteomyelitis, or chronic hepati-
tis (51). Infections with this zoonotic pathogen occur world-
wide with the possible exception of New Zealand (41). The
range of C. burnetii reservoirs is extensive and includes both
wild and domestic mammals, birds, and arthropods such as
ticks (41). In most animals, C. burnetii does not cause overt
disease. Exceptions are sheep and goats, where massive pro-
liferation of the organism in the female reproductive system
can result in late-term abortion (41). Consequently, the results
of parturition can deposit tremendous numbers of C. burnetii
in the environment, where the agent can persist for years.
Inhalation of aerosols containing C. burnetii is the typical route
of human infection. Indeed, Q fever is considered an occupa-
tional hazard associated with domestic livestock operations.
Moreover, aerosol transmission, environmental stability and a
very low infectious dose (43) make C. burnetii a potential
biowarfare agent (USA CDC, category B).
Isolates of C. burnetii derived from a variety of geographical
areas and various hosts display considerable genetic homoge-
neity when examined solely by 16S rRNA gene sequencing
(65). However, restriction fragment length polymorphism
(RFLP) analysis of genomic DNA (gDNA) reveals consider-
able heterogeneity in banding patterns (31, 33, 36, 40, 77),
indicating genetic diversity between C. burnetii isolates. Using
this method, Hendrix et al. (33) categorized 32 C. burnetii
isolates into six distinct genomic groups (I to VI). Additional
genomic variance was subsequently described by Jager et al.
(36) in their RFLP analysis of 80 isolates. Differentiation of C.
burnetii has also been achieved by sequence and/or PCR-RFLP
analysis of icd (encoding isocitrate dehydrogenase) (5, 46),
com1 (encoding an outer membrane-associated immunoreac-
tive protein) (34, 62, 83), and mucZ (known to confer a mucoid
property to bacteria) (62). The most recent and extensive sur-
vey of C. burnetii genetic diversity was reported by Glazunova
et al. (24), who used multispacer sequence typing to place 173
C. burnetii isolates into 30 different genotypic groups.
Most C. burnetii isolates harbor 1 of 4 autonomously repli-
cating plasmids termed QpH1, QpRS, QpDV, and QpDG (40,
75). These plasmids range from 32 to 42 kb in size and share a
common 25-kb “core” region along with unique regions (40,
59, 79). QpRS-like plasmid sequences are integrated into the
chromosome of some isolates (40, 60, 79). Plasmid types are
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associated with specific genomic groups. Interestingly, human
isolates within genomic groups I, II, and III were all derived
from acute disease patients, whereas human isolates within
genomic groups IV and V were all derived from chronic dis-
ease patients. These correlations led to the controversial hy-
pothesis that plasmids and their associated genome encode
pathotype-specific virulence factors (36, 40, 71). Controversy
aside, the absolute conservation of chromosomally integrated
or autonomously replicating plasmid sequences in all C. bur-
netii isolates examined to date suggests that these sequences
play a critical role in some aspect of C. burnetii biology.
The genetic diversity of C. burnetii is also revealed by pro-
duction of antigenically and structurally unique lipopolysac-
charide (LPS) molecules. Three distinct C. burnetii LPS che-
motypes have been described that are associated with specific
genomic groups (27, 28, 30, 73), and a potential link between
LPS chemotype and C. burnetii virulence potential has been
proposed (27). LPS is the only defined virulence factor of C.
burnetii (43). Virulent C. burnetii isolated from natural sources
and infections all produce a full-length LPS that is serologically
defined as “phase I.” Serial in vitro passage of phase I C.
burnetii in embryonated eggs or tissue culture results in LPS
molecules with decreasing molecular weights, culminating in
the severely truncated LPS of avirulent phase II organisms.
Phase II LPS contains lipid A and some core sugars but is
missing O-antigen sugars and appears to represent the minimal
LPS structure of C. burnetii (1, 30, 74). Two cloned LPS vari-
ants of the virulent Nine Mile phase I (NMI) isolate have been
described: Nine Mile Crazy (NMC; intermediate virulence),
producing an intermediate-length LPS, and Nine Mile phase
II (NMII; avirulent), producing a severely truncated phase
II LPS (30, 43). NMII and NMC have large chromosomal
deletions (26 and 32 kb, respectively) that eliminate open
reading frames (ORFs) involved in the biosynthesis of O-
antigen sugars, including the rare sugar virenose (6-deoxy-
3-C-methlygulose) (35, 76).
The availability of genome sequences of pathogenic bacteria
allows a rapid assessment of intrastrain/species whole genome
sequence variation by using comparative genome hybridization
(CGH) on DNA microarrays. Comparisons have been made
between strains of the same species (18, 50, 56) and between
different species of the same genus that differ in virulence
potential, environmental origin, and animal host (22, 48).
These studies provide insight into pathogen genetic diversity,
strain evolution, epidemiology of disease, and virulence poten-
tial. Moreover, CGH can be used for high-resolution molecu-
lar strain discrimination. Indeed, current serological, PCR, and
cell culture-based diagnostic methods fail to discriminate be-
tween different C. burnetii isolates (21). The genome-wide vari-
ations identified by CGH allow a more definitive analysis of the
evolutionary relatedness of bacteria than other phylogenetic
methods, such as those that rely on variation in the nucleotide
sequence of a limited number of conserved genes (e.g., rRNA
and housekeeping genes), RFLP profiles, or diversity in vari-
able-number tandem repeats (37). These methods generally do
not resolve the loss of DNA and, in the case of RFLP profiles,
a single band in one isolate can correspond to multiple bands of
different isolates, showing that loss of a restriction site does not
indicate the deletion of a whole DNA fragment and its encoded
genes (77).
The C. burnetii NMI (RSA493) genome has recently been
sequenced and consists of a circular chromosome of 1,995,275
bp and a plasmid (QpH1) of 37,393 bp that encode 2,095 and
40 ORFs, respectively (63). Analysis of coding ORFs indicates
that, although C. burnetii shares similarities in lifestyle and
parasitic strategies to other obligate intracellular bacteria, it
generally differs considerably with respect to genome size, met-
abolic and transporter capabilities, the presence of mobile
genetic elements, and the extent of genome reduction (23, 55,
57, 63, 84). To further define the genetic diversity of C. burnetii,
gDNA of 24 isolates of diverse geographical and environmen-
tal origins were hybridized to a custom Affymetrix microarray
chip (RMLchip_a) containing probe sets corresponding to all
ORFs of the NMI isolate. We present here the first C. burnetii
whole-genome phylogeny. Although the genomes of C. burnetii
isolates demonstrate considerable relatedness, some isolates
are missing a number of ORFs relative to NMI that likely
result in different biological properties. Moreover, the results
of the present study expand our understanding of the genetics
of LPS phase variation and establish a new method for classi-
fying unknown C. burnetii isolates.
MATERIALS AND METHODS
C. burnetii isolates, cultivation, and purification. The C. burnetii isolates used
in the present study are part of the culture collections maintained at the Rocky
Mountain Laboratories, National Institute of Allergy and Infectious Diseases,
Hamilton, MT, and Texas A&M University System, College Station, TX. Isolate
name, geographical/sample origin, plasmid type, clinical disease, and passage
history are listed in Table 1. Q321 is a cow’s milk isolate from Russia (75), and
Dugway 5G61-63 is a tick isolate from Dugway, Utah (68). Le Bruges was
isolated in France from an unknown source and BDT 1 was isolated in the
United States from a brown dog tick and has not been previously described. The
remaining isolates have been previously described (33). C. burnetii was propa-
gated in African green monkey kidney (Vero) fibroblasts (CCL-81; American
Type Culture Collection) grown in RPMI medium (Invitrogen) supplemented
with 2% fetal bovine serum, or in embryonated hen’s eggs, as previously de-
scribed (59). Organisms were purified from infected eggs or Vero cells by
Renografin or sucrose density gradient centrifugation (29, 59).
C. burnetii replicative vacuoles were harvested from infected Vero cells on
12-mm glass coverslips by micromanipulation. At 5 days postinfection, coverslips
were transferred to a 90-cm diameter petri dish containing approximately 10 ml
of RPMI medium. Individual vacuoles were extracted from an infected mono-
layer by using a Micromanipulator 5171 (Eppendorf), a CellTram vario manual
microinjector (Eppendorf), and TransferTips MDS (Eppendorf). The microma-
nipulator was mounted to the stage of a Zeiss Axiovert 25 inverted microscope,
and vacuole harvest was conducted at 200 magnification. The fluid contents of
harvested vacuoles (ca. 1 l) were added to 40 l of K-36 buffer (0.1 M KCl,
0.015 M NaCl, 0.05 M K2HPO4, 0.05 M KH2PO4 [pH 7.0]) in a 1.5-ml microfuge
tube, and the mixture was frozen at 80°C.
Genomic DNA isolation and amplification. Total gDNA was purified directly
from purified C. burnetii, infected guinea pig spleen homogenate (BDT isolate),
and infected yolk sac (G isolate) by one of two methods. The first method used
an UltraClean microbial DNA isolation kit (MoBio Laboratories, Inc.) according
to the protocol recommended by the supplier, with an additional heating step
(85°C for 10 min) before physical disruption of the bacterial cells. The second
method has been previously described by Samuel et al. (58). All DNA was
resuspended in distilled H2O and frozen at 20°C. Whole-genome amplification
(WGA) was conducted on total DNA yielded from 12.5 l of infected yolk sac
and directly on 1 l of C. burnetii vacuole suspension without prior DNA puri-
fication. Amplifications used a GenomiPhi DNA Amplification Kit (Amersham
Biosciences). Specifically, 1 l of DNA solution or C. burnetii vacuole suspension
was added to 9 l of sample buffer, which was heated to 95°C for 3 min and then
cooled to 4°C on ice. A total of 9 l of reaction buffer and 1 l of enzyme mix
were then added to the cooled DNA sample. The samples were incubated at
30°C for 18 h, followed by inactivation of the Phi29 DNA polymerase by heating
at 65°C for 10 min. The samples were cooled on ice and stored at 20°C. Four
separate WGA reactions were conducted on DNA from infected yolk sacs, while
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eight separate reactions were conducted on the C. burnetii vacuole suspension.
The respective reactions were pooled, and DNA was purified by using n-butanol.
Briefly, 30 l of sterile distilled H2O and 500 l of n-butanol was added to each
sample, and the mixture was vortexed for 5 s. WGA DNA was pelleted by
centrifugation at 12,000  g for 10 min, air dried, resuspended in 80 l of
distilled H2O, and then quantified spectrophotometrically.
Affymetrix array design. A custom Affymetrix GeneChip (RMLchip_a) was
utilized in the present study (39). The RMLchip_a is an antisense oligonucleotide
expression array (18-m feature size) consisting of 249,690 25-mer probe pairs,
with each C. burnetii ORF represented by 16 probe pairs that consist of a perfect-
match (PM) probe and a mismatch (MM) probe. The MM probe has a single
substitution at position 13 relative to the PM probe. To facilitate the analysis of C.
burnetii DNA with potential host cell DNA contamination, during the chip design
phase all probe set sequences were pruned against human, rat, and mouse genomes.
The same pruning process was conducted to prevent cross-hybridization to the 20
additional bacterial genome sequences on the RMLchip_a. The C. burnetii compo-
nent of the RMLchip_a consists of probe sets specific for 2,024 full-length genomic
ORFs (1,988 chromosomal ORFs and 36 plasmid ORFs) of the sequenced Nine
Mile isolate (RSA493) (63). Probe sets specific for 79 disrupted ORFs that contain
deletions or point mutations, resulting in premature stop codons or frameshifts, were
also included. Probe sets specific for one representative of the 21 IS1111A, 5 IS30,
and 3 ISAs1 IS element families were also included. The total coding region of the
C. burnetii genome is 1,705,446 bp. The probe sets on the RMLchip_a encompass ca.
30% (511,725 bp) of this region.
Microarray sample preparation and hybridization conditions. Microarray hy-
bridizations were conducted with 7 and 30 g of gDNA extracted from purified
C. burnetii and infected guinea pig spleen homogenate (BDT isolate), respec-
tively. We also used 7 and 10 g of pooled WGA DNA samples from C. burnetii
vacuole suspensions and infected yolk sacs, respectively. Total DNA was frag-
mented with DNase I (Roche Applied Science; 0.001 U/g of DNA) for 10 min
at 37°C in DNase I buffer. DNase I was denatured by heating (10 min at 98°C)
and 1 l of the fragmented gDNA was electrophoretically analyzed with an
Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.) to confirm the generation
of DNA fragments between 50 and 200 bp. Fragmented DNA was then 3 end
labeled with biotin-ddUTP for 60 min at 37°C by using a BioArray terminal
labeling kit (Enzo Life Sciences, Inc.). The fragmented, end-labeled cDNA was
added to hybridization solution that was used to probe the RMLchip_a. Target
hybridizations, RMLchip_a washing, staining, and scanning were conducted ac-
cording to the manufacturer’s suggestions at the National Institute of Allergy and
Infectious Diseases Affymetrix Core Facility (SAIC-Frederick, Inc.). Prior to
hybridization to the RMLchip_a, the gDNA samples in hybridization solution
were heated to 95°C for 5 min and then incubated for 5 min on ice, followed
by equilibration to room temperature. Hybridization was carried out for 16 h
at 50°C with rotation in a hybridization oven (Affymetrix) at 60 rpm. After
removal of the hybridization solution, the RMLchip_a was washed and stained using
a Fluidics Station 400 according to directions stated by Affymetrix for the GeneChip
Pseudomonas aeruginosa Array. Labeled RMLchip_a’s were then scanned by using
an Affymetrix GeneChip Scanner 3000.
Microarray data analysis. Images from scanned microarrays were processed
with Affymetrix GeneChip Operating Software (GCOS) version 1.2 (Affymetrix).
One to four hybridizations per isolate were performed with separately labeled
gDNA or WGA DNA. The difference in intensity value for each probe pair was
calculated by subtracting the MM probe intensity value from the PM probe
intensity value. The average difference in intensity values for the entire 16 probe
pairs for each ORF was calculated by using the statistical expression algorithm
incorporated into GCOS. Normalization between arrays was achieved by imple-
menting array-specific scaling factors that were calculated as a ratio of 500
divided by the average of the average difference in intensity values for all ORFs
represented on the RMLchip_a. For each ORF, the average difference in inten-
sity was multiplied by the array specific scaling factor. Using Partek Pro software
version 6.04.1208 (Partek), sample/reference ratios of signal intensity were cal-
culated and transformed to logarithm base 2. The ratios were then normalized by
using the median log2 ratios of zero, and the final value was calculated from the
average of all replicates. ORFs that had a log2 ratio of less than 1 were
considered absent and subjected to PCR and sequencing validation.
Microarray validation. PCR validation was conducted for all ORFs indicated
as absent by microarray. The PCR strategy used is shown in Fig. S1 in the
supplemental material. PCRs utilized primers specific to ORFs flanking putative
deletions. They were first used to amplify the two ORFs immediately flanking
polymorphic regions to determine whether potential deletions extended into the
flanking ORFs. PCR amplifications were then conducted across polymorphic
regions to determine whether ORFs within this region were deleted, contained
TABLE 1. C. burnetii isolates used in this study
Genomic
groupa
Plasmid
typeb Isolate
Isolate
designationc Phase
d Original source, yr Diseasee Passage historyf
I QpH1 Nine Mile RSA493 NMI I Montana, tick, 1935  307GP/1TC/1EP
I QpH1 Nine Mile RSA439 (clone 4) NMII II Montana, tick, 1935  90EP/1TC/4EP
I QpH1 Nine Mile RSA514 Crazy NMC I/II Montana, tick, 1935  4EP/306GP/3EP
I QpH1 Australia QD RSA425 (clone 3) Au II Australia, human blood, 1939 Acute 177EP/1TC/2EP/1VC
I QpH1 D RSA345 D II United states, human blood, 1938 Acute 81EP
I QpH1 Turkey RSA333 T II Turkey, human blood, 1948 Acute 31EP
I QpH1 African RSA334 Af I Central Africa, human blood, 1949 Acute 3HP/4EP
I QpH1 Giroud RSA431 Gi I Central Africa, human blood, 1949 Acute 2GP/2EP
I QpH1 EI Tayeb RSA342 EIT I Egypt, tick, 1967  4GP/2EP
I QpH1 Panama RSA335 Pa I Panama, chiggers, 1961  4EP
I QpH1 California 33 RSA329 Ca 33 I California, cow’s milk, 1947 Persistent 6EP
I QpH1 California 16 RSA350 Ca 16 II California, cow’s milk, 1947 Persistent 38EP
I QpH1 Ohio 314 RSA270 Oh I Ohio, cow’s milk, 1956 Persistent 4EP
II QpH1 Henzerling RSA331 He II Italy, human blood, 1945 Acute 36EP
III QpH1 Idaho Goat Q195 Id I Idaho, goat, 1981 Abortion 2EP
IV QpRS MSU Goat Q177 (Priscilla) MSU I Montana, goat cotyledon, 1980 Abortion 2EP
IV QpRS K Q154 K I Oregon, human heart valve, 1976 Endocarditis 2EP
IV QpRS P Q173 P I California, human heart valve, 1979 Endocarditis 2EP
V IP G Q212 G I Nova Scotia, human heart valve, 1981 Endocarditis 2EP
V IP S Q217 S I Montana, human liver biopsy, 1981 Hepatitis 2EP
V IP Ko Q229 Ko I Nova Scotia, human heart valve, 1982 Endocarditis 2EP
VI QpDG Dugway 7E9-12 Du 7E9-12 I Utah, rodents, 1958  3EP
UN QpDV Q321 Q321 ND Russia, cow’s milk Persistent ?/1EP
UN PTU Dugway 5G61-63 Du 5G61-63 ND Utah, tick (Dermacentor parumapertus),
1958
 ?/1EP
UN PTU BDT 1 BDT ND United States, brown dog tick
(Rhipicephalus sanguineus), 1951
 ?/1GP
UN PTU Le Bruges Le B ND France, unknown source  ?/1EP
a As previously defined by Hendrix et al. (33). UN, unassigned genomic group.
b As previously described (59) with the exception of QpDV, which was described by Valkova and Kazar (75). IP, integrated plasmid; PTU, plasmid type unknown.
c Designation of isolates used in this study.
d Phase defined by complement block titration, M. G. Peacock, Rocky Mountain Laboratories; ND, phase was not determined.
e Disease associated with each isolate. , No disease association.
f The preceding number indicates laboratory passages in guinea pig (GP); tissue culture (TC); eggs (EP); and hamsters (HP). ?, Passage prior to receipt in the author’s
laboratory unknown.
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FIG. 1. Comparison of the genomes of 22 C. burnetii isolates with the genome of the Nine Mile (RSA493) reference isolate. Labeled DNA was
hybridized to the RMLchip_a containing probe sets specific for all ORFs of the Nine Mile isolate. ORF polymorphisms were identified as ORF probe
sets showing log2 hybridization ratios lower than1 that were validated as described in Materials and Methods. Red ORFs were completely deleted, blue
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ORFs were partially deleted, and yellow ORFs contained point mutation(s) or small insertions. The number and location of each polymorphism,
consisting of single or multiple ORFs, is shown on the right. (A) Chromosomal polymorphisms 1 through 44. (B) Plasmid polymorphisms 45
through 51. The number and location of each polymorphism, consisting of either single or multiple ORFs, is shown on the right. Predicted
nonfunctional NMI ORFs containing point mutations (PM) or frameshift (FS) mutations are indicated.
FIG. 1—Continued.
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inserted DNA, or were intact. Amplification of NMI genomic DNA was con-
ducted as a control. The ORF-specific primers used in the present study are
listed in Table S1 in the supplemental material. Primer sequences were based on
the published C. burnetii Nine Mile (RSA493) sequence (63) and were manu-
factured by Sigma Genosys, LP. PCRs (50 l) containing 100 ng of gDNA were
performed by using either AccuPrime Pfx DNA polymerase (Invitrogen Corp.)
for the predicted short PCR products (4 kb) or Accuprime Taq DNA poly-
merase High Fidelity (Invitrogen Corp.) for the predicted long PCR products
(4 kb). PCR products analyzed by DNA sequencing were processed by using a
QIAquick PCR purification kit (QIAGEN) and sequenced by the RML Geno-
mics Core Facility (Rocky Mountain Laboratories, Hamilton, MT). DNA se-
quencing reactions were performed with an ABI Prism Dye Terminator Cycle
Sequencing Ready Reaction sequencing kit according to the manufacturer’s
instructions (Applied Biosystems, Inc.), and reactions were analyzed by using a
model 3700 automated DNA sequencer (Applied Biosystems, Inc.).
Phylogenetic analysis. A numerical score was assigned to each isolate ORF
based on the following criteria: 1 for present, 2 for partially deleted, 3 for absent,
and 4 for containing a point mutation or small insertion (50 bp). ORF desig-
nations were then analyzed by using PAUP software version 4.0b10 (PPC;
Sinauer Associates, Inc). Phylogenetic trees were constructed by using maxi-
mum-parsimony with equal weighting following a heuristic search.
LPS extraction and analysis. C. burnetii LPS was extracted by a modified hot
phenol method that exploits the molecule’s hydrophilic nature (30). Briefly, 1 mg
(dry weight) of purified C. burnetii was suspended in 1 ml of 50% phenol. The
sample was boiled for 10 min, incubated on ice for 5 min, and then centrifuged
at 14,000  g for 5 min. The aqueous phase was collected, and the extraction was
repeated on the pellet. The aqueous phases from both extractions were pooled
(ca. 1 ml) and vacuum dried overnight. The resulting pellet was dissolved in 100
l of distilled H2O, the sample was dried again, and the pellet was dissolved in
50 l of sample buffer. Samples were then separated on a 12.5% sodium dodecyl
sulfate-polyacrylamide gel. LPS was stained by using a SilverQuest Silver staining
kit (Invitrogen Corp).
Deposition of microarray data in the public databases. The microarray data
have been deposited in the microarray database at European Bioinformatics
Institute (http://www.ebi.ac.uk) under the accession number E-TABM-35.
RESULTS
CGH microarray analysis. We used microarray-based CGH
as a highly resolving method to explore the genetic diversity of
C. burnetii isolates from disparate sources. Beginning with se-
quence information compiled by The Institute for Genomic
Research during the genomic sequencing of C. burnetii NMI, a
custom Affymetrix GeneChip (RMLchip_a) was constructed
that contains probe sets specific for 2,103 predicted ORFs
(2,063 chromosomal and 40 plasmid ORFs) of C. burnetii (63).
Seventy-nine of these ORFs are considered nonfunctional due to
FIG. 1—Continued.
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the presence of internal frameshifts or premature stop codons
(63). NMI is considered a reference isolate of C. burnetii that is
biologically representative of acute disease isolates (33). It is the
original U.S. isolate that was obtained from a tick in Montana in
1935 (17). The genomes of 23 C. burnetii isolates and two passage
history variants of NMI, having different biological properties and
obtained from geographically diverse areas (Table 1), were com-
pared to NMI by hybridization to the RMLchip_a. Isolates in-
clude those obtained from acute and chronic human disease (en-
docarditis or hepatitis), goat placenta following abortion, cow’s
milk, rodents, ticks, and chiggers. Nineteen of these isolates reside
in genomic groups I to VI according to the nomenclature of
Hendrix et al. (33). Four ungrouped isolates, i.e., Q321, Le
Bruges, Dugway 5G61-63, and BDT 1, were also included in the
present study.
Figure 1 depicts chromosomal (Fig. 1A) and plasmid (Fig.
1B) ORF polymorphisms relative to NMI that were present in
individual C. burnetii isolates as identified by CGH. In the
present study a polymorphism is defined as a single or multiple
linked ORF(s) where negative hybridization occurred due to
complete or partial ORF deletion, point mutation(s), or DNA
insertion. The number of polymorphic ORFs ranged from 0 in
genomic group I isolates to 87 in genomic group V isolates,
which represents 4.1% of the NMI coding capacity (Table 2).
Between all isolates, a total of 139 ORF polymorphisms (109
chromosomal and 30 plasmid) were identified. A total of 34 of
these ORFs have putative functions (Table 3), while 93 encode
hypothetical proteins. The remaining 12 polymorphic ORFs
are annotated but are predicted to be nonfunctional because of
a frameshift or truncation. The number of predicted single-
event polymorphisms, i.e., changes predicted to occur once but
affecting either single or multiple ORFs, varied between iso-
lates and ranged from 0 in genomic group I isolates to 20 in
genomic group V isolates. The size of polymorphisms ranged
from a single ORF (e.g., CBU0478 in Du 7E9-12) to 18 ORFs
(e.g., plasmid ORFs CBUA0028 to CBUA0005 in genomic
group V isolates with integrated “plasmid-like” sequences).
Isolates within previously described genomic groups all had the
same polymorphisms, confirming their relatedness based on
previous RFLP studies (33).
Polymorphisms within genomic groups I to IV included six
chromosomal polymorphisms (polymorphisms 17, 25, 32, 35,
40, and 44) common to at least two genomic groups. Four
chromosomal regions of difference (RD), defined as regions
that contain polymorphisms of different sizes within the same
relative chromosomal locations, were also observed (polymor-
phisms 10 and 11, 19 to 21, 22 and 23, and 29 and 30). The
remaining 26 chromosomal polymorphisms were unique to a
single genomic group. No polymorphisms were observed with
the previously ungrouped isolates BDT and Du 5G61-63, in-
dicating that these isolates reside within genomic group I. In
contrast, ungrouped isolates Q321 and Le B contained a large
number of predicted single-event chromosomal polymor-
phisms (15 and 16, respectively). They were identical apart
from a single polymorphism encompassing CBU0069 to
CBU0072 that is present in Le B but not Q321. This polymor-
TABLE 2. ORF polymorphisms of 22 C. burnetii isolates relative to the Nine Mile reference isolate
Isolate
Chromosomal ORF polymorphism typea Plasmid ORF polymorphism typeb
% of ORFs with
polymorphisms gNo. of single-event
polymorphismsc
Point/insertion
polymorphismd
Partial
ORFse
Deleted
ORFs f
No. of single-event
polymorphismsc
Point/insertion
polymorphismd
Partial
ORFse
Deleted
ORFs f
NMI 0
D 0
Tu 0
Af 0
Gi 0
EI T 0
Pa 0
Ca 16 0
Ca 33 0
Oh 0
Id 4 7 0.3
He 8 2 18 0.9
MSU 15 2 9 27 3 2 1 8 2.3
K 15 2 9 27 3 2 1 8 2.3
P 15 2 9 27 3 2 1 8 2.3
G 18 3 4 53 2 1 26 4.1
S 18 3 4 53 2 1 26 4.1
Ko 18 3 4 53 2 1 26 4.1
Du 7E9-12 6 3 2 1 2 1 7 0.7
BDT 0
Du 5G61-63 0
Q321 15 2 8 37 2 3 9 2.8
Le B 16 2 8 41 2 3 9 3.0
a Type of polymorphism associated with any of the 2,063 NMI chromosomal ORFs.
b Type of polymorphism associated with any of the 40 NMI QpH1 plasmid ORFs.
c Predicted number of separate genetic events resulting in ORF polymorphism within each isolate.
d Number of ORFs of 250 bp presumably containing point mutations or small insertions, where the PCR indicates the entire ORF sequence is present.
e Number of partially deleted ORFs.
f Number of completely deleted ORFs.
g Percentage of NMI ORFs that are polymorphic.
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phism was also observed in genomic group V isolates. Of the
15 chromosomal polymorphisms conserved between Le B and
Q321, 12 were also present in genomic group IV isolates. Five
of these polymorphisms (21, 22, 32, 40, and 44) were also
detected in isolates of additional genomic groups, with poly-
morphisms 21 and 22 included in chromosomal RDs. The
remaining polymorphisms (16, 26, and 31) were uniquely sized
and resulted in three additional chromosomal RDs.
Seven polymorphisms (45 to 51) relative to the QpH1 plas-
mid of NMI were observed. One polymorphism (45) was
unique to genomic group V isolates that have plasmid-like
sequences integrated into the chromosome. A plasmid RD was
observed that includes polymorphism 47 of genomic groups
IV, V, Le B, and Q321 and polymorphism 46 of Du 7E9-12,
which is a subregion of polymorphism 47. A second plasmid
RD is represented by the remaining plasmid polymorphisms
(48 to 51) that were observed in genomic groups IV, VI, and
the ungrouped isolates Le B and Q321. Although the plasmid
content of Le B is unknown, it likely carries QpDV since the
plasmid polymorphisms of this isolate were identical to Q321,
which contains this plasmid (75). Only 10 ORFs were con-
served between all plasmid types and integrated plasmid-like
sequences (Table 4), with one (CBUA0009) predicted to be
nonfunctional in NMI.
Microarray validation. To experimentally validate polymor-
phisms identified by CGH, PCR (with or without DNA se-
quencing of PCR replicons) of polymorphic regions was con-
ducted on all ORFs indicated as absent. Figure S1 in the
supplemental material depicts the PCR strategy used to char-
acterize polymorphisms, and Table 5 summarizes the valida-
tion results. In general, deletions varied widely in size, ranging
from 43 bp (CBU0478 in Du 7E9-12) to 19.9 kb (CBUA0028
to CBUA0005 in the genomic group V isolates). The majority
of polymorphisms consisted of completely deleted individual or
linked ORFs with the deletion not extending into flanking ORFs.
Polymorphisms that consisted of partially deleted ORFs, either at
the boundary of a multiple ORF polymorphism or as a single
ORF polymorphism, were also identified (e.g., polymorphisms 6
and 8, respectively). Some PCR products were larger than pre-
dicted for a deleted ORF(s), indicating the presence of inserted
DNA, which in some cases (e.g., polymorphisms 1, 4, and 22) was
confirmed by DNA sequencing. PCR products indicating the
presence of full-length ORFs that were called absent by micro-
array were obtained for 5 of 10 ORFs of 250 bp (polymor-
phisms 5, 24, 40, 44, and 48). DNA sequencing of PCR prod-
ucts specific to polymorphisms 5, 40, and 48 revealed point
mutations that presumably prevented hybridization of gDNA
to the predominantly overlapping probe pairs corresponding to
these smaller ORFs. Polymorphism 5 (CBU0380) contained a
synonymous change, whereas polymorphisms 40 (CBU1912)
and 48 (CBUA0025) contained nonsynonymous changes re-
sulting in frameshifts that are predicted to disrupt gene func-
tion. Although not confirmed by DNA sequencing, point mu-
tation(s) in CBU1014 and CBU2053 also likely explain
polymorphisms 22 and 44, respectively. PCR validation iden-
tified two cases (polymorphisms 4 and 30) where flanking
genes (CBU0281, CBU0284, and CBU1208) contained small
partial deletions not detected by CGH. In all cases examined,
sequencing of PCR products revealed that the deletion bound-
aries of a given polymorphism were the same for isolates within
the same genomic group. Between genomic groups, deletion
boundaries could vary (e.g., polymorphisms 19 to 21 in
genomic groups II, IV, and V). Validation results also indi-
cated a high degree of genome synteny between C. burnetii
isolates as PCR products were obtained for all polymorphisms.
TABLE 3. Nine Mile ORFs with a predicted function
that are completely or partially deleted in at
least one C. burnetii isolate
ORF type and IDa Description Size(bp)
Chromosomal ORFs
CBU0071 Ankyrin repeat protein 972
CBU0072 Ankyrin repeat domain protein 1,197
CBU0166 Condensation domain protein 762
CBU0167 Polyketide biosynthesis enoyl-CoA
hydrataseb
561
CBU0168 Acyl carrier protein, putative 276
CBU0282 Transcriptional regulator 510
CBU0562 ATPase (AAA superfamily) 1,278
CBU0598 MutT/NUDIX family protein 543
CBU0768 Multidrug resistance protein B 1,494
CBU0792 Multidrug resistance protein B 1,377
CBU0953 Amino acid permease 1,311
CBU1017 ATPase (AAA superfamily) 1,140
CBU1021 Nucleotidyltransferase 441
CBU1022 Nucleotidyltransferase 297
CBU1213 Ankyrin repeat domain protein 1,971
CBU1392 2-phosphosulfolactate phosphatase 693
CBU1609 Ankyrin repeat protein 1,449
CBU1664 CBS domain protein 591
CBU1774 Tetratricopeptide repeat family protein 381
CBU1800 Transporter 756
CBU1804 Transcriptional regulator, LuxR family,
putative
252
CBU1805 Transcriptional regulator, LuxR family 381
CBU1806 DNA polymerase domain protein 285
CBU1991 Plasmid stability protein-RelB 252
CBU1992 Plasmid stability protein-RelE 273
CBU2026 Lipoprotein, putative 303
Plasmid ORFs
CBUA0003 Cell filamentation protein fic 456
CBUA0005 DNA integration/recombination/
invertion protein
567
CBUA0016 CbhE protein 1,023
CBUA0032 3,5-cyclic-nucleotide
phosphodiesterase
744
CBUA0036 ParB protein, putative 867
CBUA0037 ParA protein, putative 1,218
CBUA0038 RepB protein, putative 1,002
CBUA0039 RepA protein, putative 1,287
a ID, identification number.
b CoA, coenzyme A.
TABLE 4. Conserved ORFs of QpH1, QpRS, QpDV, QpDG,
and integrated plasmid sequences
Gene IDa Predicted protein function
CBUA0006..............Hypothetical protein
CBUA0007..............Hypothetical protein
CBUA0008..............Phage tail assembly protein
CBUA0009..............Nemacidial toxin, putative, degenerate
CBUA0010..............Site-specific recombinase, phage integrase family
CBUA0011..............Probable integrase/recombinase ripX
CBUA0012..............Hypothetical protein
CBUA0013..............Hypothetical protein
CBUA0023..............Hypothetical protein
CBUA0027..............DNA-binding protein
a ID, identification number.
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TABLE 5. Characterization of genomic polymorphisms
Polymorphism
no. Polymorphic region
a
Size of
corresponding
region in
NMI (bp)b
PCR/sequencing resultsc
1 CBU0007 to CBU0008 1,785 Insertion of 7 kb of DNA adjacent to transposase (CBU0006); PCR
products were not obtained for CBU0007 or CBU0008
2 CBU0069 to CBU0072 3,909 2.7-kb deletion with flanking IS1111A transposon-like sequenced,f
3 CBU0166 to CBU0173 4,739 3.2-kb deletion and insertion of unknown DNAd,f
4 CBU0282 to CBU0283 1,482 Large insertion (4 kb) that eliminates CBU0282, CBU0283, the first four
codons of CBU0284, and the last six codons of CBU0281 and is flanked
by 5-bp repeatsd,e,f
5 CBU0380 253 Single synonymous point mutation (TCG to TCC)d
6 CBU0398 to CBU0400 1,143 793-bp deletion that elminates the last 153 codons of CBU0398 and first 102
codons of CBU0400 d
7 CBU0401 291 Small deletion of 50 bp
8 CBU0464 627 470-bp deletion that eliminates the first 158 codonsd,g
9 CBU0478 410 43-bp deletion flanked by 6-bp repeatd,e
10 CBU0562 to CBU0563 3,003 2.5-kb deletion
11 CBU0563 880 800-bp deletion
12 CBU0598 606 600-bp deletion
13 CBU0602 to CBU0604 2,299 2.013-kb deletion that eliminates CBU0602 to CBU604d
14 CBU0767 to CBU0768 2,476 Large insertion (7 kb)f
15a CBU0791 to CBU0793 4,371 2.7-kb deletion in MSU, K and P isolates
15b CBU0791 to CBU0793 4,371 2.1-kb deletion in Le B and Q321 isolates
16 CBU0878 to CBU0881 4,878 3.1-kb deletion adjacent to disrupted transpoase (CBU0882)
17 CBU0881 2,321 1-kb deletion
18 CBU0903 2,524 2.4-kb deletion
19 CBU0917 to CBU0919 4,869 3.8-kb deletion
20 CBU0918 4,869 2-kb deletion
21 CBU0919 1,574 700-bp deletion
22 CBU0949 to CBU0953 6,954 5.7-kb deletion and insertion of unknown DNA that eliminates the first
119 codons of CBU0949d,f
23 CBU0950 to CBU0953 6,443 5.9-kb deletion
24 CBU1014 1,029 No deletion detectable, probable point mutation
25 CBU1016 to CBU1019 2,759 2.463-kb deletion that eliminates CBU1016 to CBU1019 and is flanked by
175-bp repeats that are 89% identicald,e
26 CBU1016 to CBU1022 4,695 4.114-kb deletion that eliminates CBU1016 to CBU1022 and is flanked by
175-bp repeats that are 89% identicald,e
27 CBU1026 505 Small deletion of less than 50 bp
28 CBU1105 to CBU1110 5,875 4.5-kb deletion that is adjacent to a transposase (CBU1104)
29 CBU1209 to CBU1213 6,614 5.987-kb deletion that eliminates the first 16 codons of CBU1214, CBU1213
to CBU1210, and the first 295 codons of CBU1209; deleted region is near
a transposase (CBU1218)d
30 CBU1209 to CBU1215 7,301 7.342-kb deletion that eliminates the last 39 codons of CBU1208, CBU1209
to CBU1214, and the last 137 codons of CBU1215; deleted region is near
a transposase (CBU1218)d
31 CBU1210 to CBU1216 7,636 6.674-kb deletion that eliminates CBU1210 to CBU1215 and the first 395
codons of CBU1216; deleted region is near a transposase (CBU1218)d
32 CBU1271 3,197 1.659-kb deletion with 9-bp flanking repeats that eliminates CBU1271;
deleted region is adjacent to a transposase (CBU1270)d,e
33 CBU1348 508 500-bp deletion
34 CBU1390 to CBU1392 8,304 3-kb deletion
35 CBU1409 1,448 1,091-bp deletion flanked by two 104-bp repeats that are 94% identicald,e
36 CBU1609 to CBU1616 4,720 4.426-kb deletion that eliminates the first 451 codons of CBU1609, CBU1610
to CBU1615, and the last 98 codons of CBU1616 and is flanked by 5-bp
repeatsd,e
37 CBU1664 to CBU1668 4,419 4.2-kb deletion
38 CBU1773 to CBU1777 2,012 1.7-kb deletion
39 CBU1800 to CBU1806 3,783 3.316-kb deletion that eliminates the first 219 codons of CBU1800 and
CBU1801 to CBU1806 and is flanked by 3-bp repeatsd,e
40 CBU1912 337 Two point mutations and insertion of a single base paird
41 CBU1988 to CBU1991 2,430 2.257-kb deletion that eliminates CBU1988 to CBU1991 (containing the
transposase CBU1990) and the first 27 codons of CBU1992 and is flanked
by two 49-bp repeats that are 92% identicald,e
42 CBU2021 to CBU2022 2,835 1,881-bp deletion that eliminates the majority of previously disrupted
CBU2022 and the first 160 codons of CBU2021, flanked by 8-bp repeats;
83-bp insertion is also present at the start of CBU2022d,e
43 CBU2026 745 400-bp deletion
44 CBU2053 384 No deletion detected, probable point mutation
Continued on following page
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Analysis of a chromosomal and plasmid RD. Sequence anal-
ysis of polymorphisms 29 to 31, representing a C. burnetii
chromosomal RD, suggested this RD was generated by unique
deletion events within this region. Polymorphism 29 consisted
of an 6-kb deletion (CBU1209 to CBU1214), while the de-
letion compromising polymorphism 31 was 6.7 kb in size
(CBU1210 to CBU1216). Polymorphism 30 (CBU1209 to
CBU1215), consisted of an 7.3-kb deletion that had a differ-
ent 5 deletion point from polymorphism 29.
Polymorphisms 48 to 51 (CBUA0024 to CBUA0026) consti-
tute a plasmid RD shared between QpRS, QpDV, and QpDG.
Microarray validation indicated that CBUA0026 contains an in-
sertion of variable size. Specifically, in QpRS CBUA0026 is dis-
rupted by a 3,079-bp insertion. Remnants of the same insertion
were present in CBUA0026 of QpDV and QpDG, consisting of
777 and 2,676 bp of the 3 sequence, respectively. Further poly-
morphisms in this RD were observed in QpDV and QpDG
that consisted of deletion of part of CBUA0026, all of CBUA
0025, and part (QpDV) or all (QpDG) of CBUA0024. Collec-
tively, these data suggest these and other RDs are hotspots of
genomic sequence variation.
Putative functions of polymorphic ORFs. C. burnetii encodes
a unusually high proportion of hypothetical proteins (63). Ac-
cordingly, our analysis showed that 93 (67%) of polymorphic
ORFs are annotated as encoding hypothetical proteins. An
additional 12 (9%) are annotated as nonfunctional. The re-
maining polymorphic ORFs have a range of predicted cellular
functions, including metabolic control, DNA/RNA processing,
nutrient transport, stress response, plasmid stability, and puta-
tive host function modulation (Table 3).
Five polymorphic ORFs are predicted to encode proteins
containing ankyrin or tetratrico peptide repeats, domains typ-
ically found in eukaryotic proteins that facilitate protein-pro-
tein interactions (25, 44). In eukaryotes, proteins with these
domains serve a diverse set of functions involving cytoskeletal
interactions, transcriptional regulation, signal transduction,
and cell cycle regulation (25, 44). Of the 14 ankyrin repeat
proteins (ANKs) encoded by the C. burnetii genome, 4
(CBU0071, CBU0072, CBU1213, and CBU1609) were poly-
morphic: 3 in genomic group V and Le B and 1 in genomic
groups II, IV, and Q321. In genomic group V isolates, one
polymorphic ORF (CBU1774) was predicted to encode a tet-
ratrico peptide repeat protein.
Sixteen polymorphic ORFs were common to genomic
groups IV and V and the Q321 and LeB isolates. One of these,
CBUA0016 (cbhE), was previously thought to be specific to
isolates causing acute disease (42), an idea later discounted
upon analysis of a larger group of isolates (65). A second
polymorphic ORF (CBU0952) encodes a 28-kDa immunodom-
inant outer membrane protein termed AdaA that was previously
found to be synthesized only by acute disease isolates in
genomic groups I and II (82). A third polymorphic ORF
(CBU0953) encodes an amino acid permease. ORFs encoding
14 amino acid and 3 peptide transporters are present in the C.
burnetii genome, suggesting functional redundancy within this
family of proteins (63).
In addition to ANKs and amino acid/peptide transporters,
polymorphisms were identified in seven additional ORFs that
are part of large gene families. First, two of at least five pre-
dicted nucleotidyltransferases, a family of proteins with roles in
DNA repair, transcription, DNA replication and RNA pro-
cessing, were polymorphic in Q321 and Le B, and one was
polymorphic in genomic group IV isolates. Second, 2 of 21
predicted ATPases, proteins associated with a variety of cellu-
TABLE 5—Continued
Polymorphism
no. Polymorphic region
a
Size of
corresponding
region in
NMI (bp)b
PCR/sequencing resultsc
45 CBUA0028 to CBUA0005 13,958 Integration of plasmid genes (CBUA0006 to CBUA0013 and CBUA0023
to CBUA0027) between the chromosomal genes CBU1710 and
CBU1711 results in loss of CBUA0028 to CBUA0005g
46 CBUA0014 to CBUA0018 3,947 3.5-kb deletion
47 CBUA0014 to CBUA0022 7,425 7.0-kb deletion and corresponding 3-bp insertion that eliminates
CBUA0014 to CBUA0021 and the first 24 codons of CBUA0022d,f,g
48 CBUA0025 748 A single 2-bp insertion and two 1-bp deletionsd
49 CBUA0026 1,229 3.079-kb insertion containing cbbE at nucleotide 147d, f, g
50 CBUA0024 to CBUA0026 2,113 1.278-kb insertion relative to QpH1; QpDV has the same 3.079-kb
insertion within CBUA0026 as QpRS; a subsequent 1.802-kb deletion
eliminated the last 777 bp of the QpRS deletion, the last 44 codons of
CBUA0024, CBUA0025, and the first 48 codons of CBUA0026d,f
51 CBUA0024 to CBUA0026 2,113 700-bp deletion relative to QpH1; QpDG has the same 3.079-kb
insertion within CBUA0026 as QpRS; a subsequent 600-bp insertion
eliminated the last 2,676 bp of the 3.079-kb insertion, CBUA0024 and
CBUA0025, and the first 48 codons of CBUA0026d, f, g
a Region containing polymorphic DNA as indicated by microarray analysis.
b Size of the polymorphic region, including flanking intergenic regions, based on the published NMI sequence (63).
c Polymorphisms were examined by PCR with or without DNA sequencing of the PCR product. Polymorphism sizes were calculated by subtracting the size of the
PCR fragment obtained for each polymorphic region from the predicted size of products based on the NMI genome sequence, which was confirmed by PCR of NMI
genomic DNA.
d Polymorphic regions further analyzed by end sequencing of PCR products.
e Polymorphisms that contain flanking repeat sequences.
f Polymorphisms that result from insertion of new DNA.
g Confirmed with published sequence data.
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lar functions, were polymorphic in genomic group IV, while
one was polymorphic in genomic groups II, III, Q321, and Le
B. Lastly, two of five ORFs predicted to encode multidrug
resistance B proteins were polymorphic in genomic group IV,
Q321, and Le B.
The acute disease isolate He contains a unique polymor-
phism (polymorphism 41) that encompasses relB (CBU1991)
and the beginning of relE (CBU1992). In Escherichia coli, these
genes regulate the stringent response to amino acid starvation
that results in inhibition of translation (11, 12). A second
unique He polymorphism (polymorphism 11; CBU0598) is
predicted to encode a protein that is part of the MutT/NUDIX
(nucleoside diphosphate linked to some other moiety, X) fam-
ily of proteins, a family consisting of widely distributed en-
zymes that function by removing potentially hazardous metab-
olites and/or modulating the buildup of biochemical pathway
intermediates (6). Genomic group V isolates contained two
polymorphic ORFs with homology to luxR. LuxR is a transcrip-
tional activator that acts as a receptor for molecules involved in
bacterial quorum sensing (26).
Possible mechanisms of polymorphism generation. Micro-
array validation indicated that most polymorphisms were
generated via DNA insertion or DNA excision and that
these events were likely facilitated by flanking repetitive
sequences or transposon-like sequences. We divided poly-
morphisms into five categories based on proximity to repeat
sequences or transposases and, if present, the character of
inserted DNA. The first category was polymorphisms con-
sisting of deletions that are immediately flanked by repeat
sequences. These sequences were typically small (9 bp),
but in four cases large repeats ranging in size from 49 to 175
bp were observed (polymorphisms 25, 26, 35, and 41). Inter-
estingly, the largest of these repeats was a family of three,
having ca. 89% identity, with one repeat each located between
CBU1015 and CBU1016, CBU1019 and CBU1020, and CBU
1022 and CBU1023. In genomic groups II, III, and V, homol-
ogous recombination probably occurred between the first two
repeats resulting in the deletion of CBU1016 to CBU1019
(polymorphism 25), while recombination between the first and
third repeat likely resulted in deletion of CBU1016 and
CBU1022 (polymorphism 26) in Q321 and Le B. A second
category was polymorphisms consisting of deletions that are
less than five ORFs away from a transposase (polymorphisms
1, 16, 28, 29 to 31, and 32). A third category was polymor-
phisms consisting of deletions where the corresponding DNA
in NMI contains a transposase (polymorphism 41), suggesting
that the excision of this element in other isolates resulted in
this polymorphism. A fourth category was polymorphisms that
resulted from DNA insertion. In all but one case, the inserted
DNA had no matches to sequences in the National Center for
Biotechnology Information database (http://www.ncbi.nlm
.nih.gov/BLAST/) and presumably represents novel C. burnetii
sequences. The exception was an insertion of an IS1111A
transposase-like sequence in polymorphism 2. The fifth cate-
gory consisted of “clean” deletions whereby an entire region
was missing and with no repeat sequences in the immediate
vicinity (e.g., polymorphism 31).
LPS phase variation. The only known difference between
virulent phase I and avirulent phase II C. burnetii is produc-
tion of a severely truncated LPS by phase II organisms (2).
To better understand the genetic basis of LPS phase varia-
tion and the attenuated virulence of C. burnetii phase vari-
ants, we conducted CGH of the genomes of NMC, NMII,
and the Australian QD (Au) isolate. The LPS phase varia-
FIG. 2. LPS profiles and ORF polymorphisms of C. burnetii isolates
synthesizing different LPS chemotypes. (A) Silver-stained sodium dodecyl
sulfate–15% polyacrylamide gel electrophoresis profiles of purified LPS
molecules from C. burnetii Nine Mile I (NMI), Nine Mile II (NMII), Nine
Mile Crazy (NMC), and Australia QD (Au) isolates. The relative sizes of
molecular mass markers in kilodaltons are shown on the left. (B) Com-
parison of the genomes of NMII, NMC, and Au isolates with the genome
of the Nine Mile (RSA493) reference isolate. Labeled DNA was hybrid-
ized to the RMLchip_a containing probe sets specific for all ORFs of the
Nine Mile isolate. ORF polymorphisms were identified as ORF probe
sets showing log2 hybridization ratios lower than 1. Red ORFs were
completely deleted and blue ORFs were partially deleted. Partial ORFs
that were previously identified by Hoover at al. (35), but not detected by
the CGH, are depicted in green.
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tion phenomenon is illustrated in Fig. 2A. NMII produced a
severely truncated LPS (2.5 kDa) relative to the laddered
molecule of NMI (19, 15, and 14.3 kDa). NMC pro-
duced an intermediate length LPS (14.3 kDa). The Au
isolate, subjected to 177 egg passages and serologically de-
fined as phase II, produced an LPS with a molecular mass
similar to that of NMII (2.5 kDa). The only NMII and
NMC polymorphisms revealed by CGH were 20 ORFs
(CBU0679 to CBU0698) and 24 ORFs (CBU0676 to
CBU0699), respectively, that are included in the deletions
previously described by Hoover et al. (35) (Fig. 2B). No
other polymorphisms were detected in either isolate. Inter-
estingly, the Au isolate contained no polymorphisms, indi-
cating that a large deletion is not required for LPS phase
variation.
CGH using whole-genome amplified DNA. Obtaining puri-
fied C. burnetii is an arduous process that requires purification
of the organism from cell culture or embryonated eggs in a
biosafety level 3 laboratory setting. We therefore tested whether
C. burnetii DNA derived from a small amount of crude sample
was suitable for CGH analysis. Whole-genome amplification
was conducted on total DNA extracted from 50 l of yolk sac
infected with the G isolate and directly on ca. 20% of the
content of a C. burnetii replicative vacuole containing NMII
that was harvested from a Vero cell monolayer by micro-
manipulation. Amplified DNA was labeled and hybridized to
the RMLchip_a. Hybridization profiles of these samples were
identical to those obtained using gDNA extracted from puri-
fied NMII and G bacteria (data not shown).
Phylogenetic analysis of C. burnetii isolates. The phyloge-
netic relationships between the isolates used in the present
study (excluding NMII and NMC) were analyzed by using
PAUP software. Phylogenetic trees were constructed using
microarray data based on hybridization signals of all 2,103
chromosomal and plasmid ORFs (Fig. 3A), 2,063 chromo-
somal ORFs (Fig. 3B), or 40 plasmid ORFs (Fig. 3C). This
analysis confirmed the RFLP-based genomic groupings (I to
VI) as previously proposed by Hendrix et al. (33). Although,
the Id and He isolates both harbor QpH1, they were more
related to each other than to genomic group I isolates that also
carry this plasmid. Indeed, if only chromosomal polymor-
phisms are considered, the Du 7E9-12 isolate was most closely
related to genomic group I; however, when considering just
plasmid polymorphisms, this isolate was most similar to
genomic group IV isolates. Genomic group V isolates, having
the greatest number of polymorphic ORFs with 87, were most
divergent from genomic group I. Q321 and Le B isolates were
most closely related to genomic group IV isolates; however,
unique polymorphisms indicate that they represent two novel
FIG. 3. Parsimony analysis of chromosomal and plasmid ORF con-
tent of C. burnetii isolates. Phylogenetic trees were constructed by
using both chromosomal and plasmid ORFs (with 123 of 132 variable
characters being parsimony informative and equally weighted) (A), chro-
mosomal ORFs (with 93 of 102 variable characters being parsimony
informative and equally weighted) (B), or plasmid ORFs (with all 30
variable characters being parsimony informative and equally weighted)
(C). One of the two most parsimonious trees for each of these groups
is depicted. (See Fig. S2 in the supplemental material for the alterna-
tive tree.) Proposed genomic groups (I to VIII) are shown in panel A.
The horizontal bar indicates the number of character changes.
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genomic groups of C. burnetii referred to here as genomic
groups VII and VIII, respectively.
DISCUSSION
In this study we used CGH to detail the extent of genomic
diversity of 24 C. burnetii isolates obtained from disparate geo-
graphical and environmental sources. In all isolates combined,
139 ORFs are polymorphic relative to the NMI reference isolate,
with the majority being complete ORF deletions. Twenty-five
polymorphisms are partial ORF deletions, point mutations, or
small insertions within ORFs that also result in no microarray
hybridization signal, with a small number of these predicted to be
functional. The lack of broad C. burnetii genetic variance is in
keeping with the organism’s obligate intracellular lifestyle that
limits opportunities for genetic exchange. Indeed, as previously
described (63), C. burnetii ORFs involved in a competence
system for the uptake of DNA, i.e., ComA (CBU0855), ComF
(CBU0464), and ComE (CBU0532), contain frameshifts, sug-
gesting the organism is no longer naturally competent. In con-
trast, Legionella pneumophila, a phylogenetically close relative
of C. burnetii, is naturally competent (69).
Consistent with other obligate intracellular bacteria (3, 23,
55, 84), and as proposed by Seshadri et al. (63), our results
suggest that the C. burnetii genome is undergoing reductive
evolution. Accordingly, we found very few polymorphisms result-
ing from DNA insertion. The C. burnetii genome contains 83
pseudogenes, 79 of which are represented on the RMLchip_a.
Twelve pseudogenes (15.2%) are completely or partially de-
leted in at least one C. burnetii isolate. Conversely, only 6.9%
of coding ORFs are deleted; thus, nonfunctional ORFs are
apparently being targeted for deletion at a higher frequency
than coding ORFs. Moreover, among deleted functional
ORFs, there appears to be a bias toward deletion of those with
potential functional redundancy. For example, two of five pre-
dicted nucleotidyltransferases are missing in Q321 and Le B
isolates. Other examples include the deletion of 4 of 14 ankyrin
repeat proteins, 2 of 21 predicted ATPases, and 2 of 5 multi-
drug resistance B proteins.
Hendrix et al. (33) were equivocal on the genetic distance
between genomic groups I, II, and III as each had a distinct
RFLP pattern, but all harbored the same plasmid (QpH1). The
ability of CGH to screen every ORF in the C. burnetii genome
allowed us to confirm that isolates within genomic groups I,
II, and III are indeed genetically distinct. Eight and four
chromosomal polymorphisms distinguish genomic group II
and III isolates, respectively, from genomic group I isolates,
and six polymorphisms distinguish genomic group II isolates
from genomic group III isolates. Phylogenetic trees con-
structed using CGH data suggest a divergent evolution
whereby genomic group I is the ancestor of genomic group
III and genomic group III is the ancestor of genomic group
II (Fig. 3). Genomic group I isolates were acquired from
geographically diverse locations including Australia, United
States, Africa, Turkey, and Panama, with the dates of iso-
lation ranging from 1935 to 1967. Interestingly, our results
indicate that the gene content of these isolates is exactly the
same relative to NMI, suggesting a worldwide spread of a
common ancestor that has since undergone limited evolu-
tion. C. burnetii genome content can also vary among iso-
lates obtained at a similar time and location. Specifically, Du
7E9-12 (rodent isolate) and Du 5G61-63 (tick isolate) were
both obtained in Dugway, Utah, in 1958, but only Du 7E9-12
has polymorphisms relative to NMI that are largely the
consequence of its carriage of the plasmid QpDG. We also
determined the evolutionary relationships of four isolates
previously ungrouped by RFLP analysis. BDT and Du
5G61-63 have no ORF polymorphisms relative to genomic
group I isolates, and hence, fall within this genomic group.
Q321 and Le B are highly similar to the genomic group IV
isolates, suggesting a recent common ancestor, yet they have
diverged enough to form two new genomic groups (VII and
VIII, respectively). Interestingly, the only difference be-
tween Le B and Q321 is polymorphism 2, which is present in
Le B and genomic group V isolates. Sequencing indicates
this polymorphism resulted from insertion of an IS1111
transposon-like sequence at the same location. Genomic
groups IV, V, VII, and VIII comprise a distinct clade from
genomic groups I, II, III and VI. Within this clade, genomic
group V is the most divergent from NMI, being most closely
related to the genomic groups IV, VII, and VIII.
Although predisposing host factors are clearly important in
the development of human acute or chronic Q fever (32, 51),
C. burnetii isolates also exhibit distinct phenotypes in terms of
infectivity of cell culture (53), cytopathic effects on host cells
(53, 66), and pathogenicity in animal models of Q fever (43, 64,
68). The general consensus of these studies is that the NMI
reference isolate (genomic group I), biologically representative
of human acute disease isolates, is more infectious, grows
faster in cell culture, and is more virulent in animal models of
infection than chronic disease isolates of genomic groups IV
and V. Evidence of C. burnetii pathotype-specific ORFs was
recently provided by Glazunova et al. (24), who found by multi-
spacer sequence typing analysis that both plasmid type and
genotype correlate with disease outcome. The CGH identifi-
cation in the present study of polymorphic ORFs associated
with chronic disease isolates and isolates of attenuated viru-
lence allows speculation concerning their roles in Coxiella
pathogenicity and disease outcome.
The degree of variance between NMI and chronic disease
isolates of genomic groups IV and V ranged from 2.3% (51
polymorphic ORFs) to 4.1% (87 polymorphic ORFs), respec-
tively, with most polymorphic ORFs encoding hypothetical
proteins. Only seven chromosomal and nine plasmid ORFs are
polymorphic in both genomic groups, suggesting the loss of
these ORFs may result in the unique phenotypes of these
isolates. The NMI genome contains 14 ANK-encoding ORFs
(63) and, although these proteins are rare in prokaryotes,
ANKs are also found in the intracellular bacteria Legionella
pneumophila (9), Anaplasma spp. (7, 49), Ehrlichia ruminan-
tium (15), Wolbachia pipientis (20, 80), and Rickettsia spp. (4,
47), where they are suspected of modulating host functions.
Four ANK-encoding ORFs are missing in genomic group IV
and V isolates, with one (CBU1609) having homology to AnkA
of A. phagocytophilum (49). In A. phagocytophilum-infected
human promyelocytic leukemia HL-60 cells, AnkA is secreted,
binds host DNA, and possibly regulates transcription (8, 49).
The absence of CBU1609 and other ANK-encoding genes in
C. burnetii chronic disease isolates indicates they are not re-
quired for potential modulation of host gene function during
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the disease process, with the caveat that ANK proteins may be
functionally redundant. Two ORFs (CBU1804 and CBU1805)
encoding proteins with similarity to the quorum-sensing regu-
lator LuxR were deleted in genomic group V isolates; however,
the lack of additional ORFs related to quorum sensing within
the C. burnetii genome suggests these ORFs serve other regu-
latory functions. Although one or a few polymorphic ORFs
may explain the association of C. burnetii genomic groups with
chronic disease, another possibility is that deleted ORFs in
toto simply result in the slower growth of these isolates and,
consequently, the stimulation of an attenuated immune re-
sponse. Indeed, slow growth resulting from a dramatically re-
duced genome is thought to contribute to Mycobacterium lep-
rae’s known ability to cause chronic infection (13, 81).
Du 7E9-12 of genomic group VI represents a naturally
occurring isolate that is weakly pathogenic in a guinea pig
model of infection (68). It contains six chromosomal and eight
plasmid polymorphisms relative to NMI. However, only one
unique polymorphism is predicted to result in loss of a func-
tional ORF. It consists of a partial deletion of CBU0478 which
encodes a hypothetical protein. This presents the possibility
that CBU0478 is necessary for virulence. There is precedence
for small genetic differences conferring dramatically different
virulence properties in obligate intracellular bacterial patho-
gens. For example, the gene contents of Chlamydia trachomatis
and C. muridarum (formally C. trachomatis, biovar mouse
pneumonitis), human and mouse specific pathogens, respec-
tively, are 99% identical (52). However, these pathogens
have a strict tropism for their respective animal hosts, a phe-
nomenon apparently conferred by just a few genes in a small
chlamydial plasticity zone (45).
Collectively, 10 ORFs are polymorphic in acute disease iso-
lates of genomic groups II and III. Three ORFs—CBU1991,
CBU1992, and CBU0598—predicted to encode RelB, RelE,
and a MutT/NUDIX family protein, respectively, are polymor-
phic in the He isolate of genomic group II. The loss of RelB
and RelE, which regulate the stringent response (11, 12), might
affect the stationary-phase physiology of the He isolate and,
consequently, development of the stable small cell develop-
mental form (14). The absence of CBU0598, might limit the
He isolate’s ability to detoxify hazardous materials or prevent
unbalanced buildup of normal metabolites (6), thereby detri-
mentally affecting its growth. Both hypotheses should be test-
able using in vitro infection models.
We recognize caveats in our attempt to correlate C. burnetii
genetic polymorphisms with specific biological and virulence
properties of isolates. First and foremost, our analysis is uni-
directional in that all isolates were compared to the sequenced
NMI isolate. As such, we cannot ascertain the level of novel
coding capacity carried by tested isolates, a distinct possibility
considering the range of isolate genome sizes roughly deter-
mined by pulse gel electrophoresis (78). Second, the tiled oli-
gonucleotide probe sets on the RMLchip_a cover ca. 30% of
the NMI coding capacity. Therefore, mutations or deletions
outside of this region will not be detected. It is also possible
that some insertions and point mutations within tiled regions
were not detected. We were initially concerned that genomic
nucleotide sequence variation between NMI and test isolates
might result in negative hybridization signals for intact and
functional genes. However, nearly all polymorphisms were
confirmed by PCR validation as true deletions, with only the
occasional polymorphism resulting from synonymous sequence
variation.
Although the impact of most polymorphic ORFs on C. bur-
netii virulence is speculative, deletion of ORFs involved in LPS
biosynthesis is clearly associated with attenuated virulence
(51). Our CGH results for NMC and NMII producing trun-
cated LPS are consistent with previous studies showing each
variant with a single large chromosomal deletion (35, 76). The
NMC deletion includes the 21 ORFs missing in NMII and
extends by two ORFs on each side of the NMII deletion (35).
Most deleted ORFs are predicted to function in O-antigen
biosynthesis, and their absence explains the intermediate trun-
cation of NMC LPS. However, their absence does not explain
why NMII, with its smaller deletion, produces a more trun-
cated LPS than NMC. NMII likely has an additional point/
frameshift mutation, small deletion, or transposon insertion in
a gene early in the LPS biosynthetic pathway that is not de-
tected by CGH. An analogous situation may exist with the Au
isolate, which produces a severely truncated LPS similar to
NMII but is identical to NMI by CGH. Thus, our data confirm
not only that large chromosomal deletions are not required for
C. burnetii LPS phase variation, as previously proposed by
Thompson et al. (72), but also that the avirulence of NMII C.
burnetii appears to be entirely attributable to deficient LPS
production since other ORF deletions were not detected.
Plasmid polymorphisms specific to QpH1, QpRS, QpDV, and
integrated plasmid-like sequences were confirmed via comparison
with their deciphered sequences (38, 63, 79), while polymor-
phisms of QpDG are described here for the first time. Nine
predicted functional plasmid ORFs are conserved among all plas-
mid types or integrated-plasmid sequences. Interestingly, two of
these ORFs, CBUA0008 and CBUA0010, encode proteins that
exhibit similarity to phage proteins involved in tail assembly and
site-specific recombination, respectively. These ORFs may be
remnants of a phage that had integrated into the C. burnetii
plasmid. Flanked by these phage genes is a degenerate ORF
(CBUA0009) annotated as a putative toxin. This protein has the
highest similarity to insecticidal and nematocidal toxin synthe-
sized by the waterborne bacterium Chromobacterium violaceum
(16) and nematode symbionts Xenorhabdus bovienii and Photoh-
abdus luminescens (10, 19), suggesting it was acquired by C. bur-
netii via horizontal transfer mediated by phage integration. This
ORF may have been beneficial to a C. burnetii progenitor with an
insect host range. Interestingly, the closest relative of C. burnetii is
Rickettsiella grylli, a cricket pathogen (54). Excluding phage-re-
lated ORFs, seven plasmid ORFs are conserved among all C.
burnetii isolates examined in the present study, suggesting a crit-
ical role in some aspect of C. burnetii intracellular parasitism.
Only CBUA0011 has an annotated function, with similarity to
ripX of Bacillus subtilis, a gene involved in chromosomal parti-
tioning (61).
Movement of mobile genetic elements clearly contributes to
C. burnetii genomic plasticity. C. burnetii contains a large num-
ber of insertion sequences (IS elements) (63) relative to most
obligate intracellular bacteria (13, 47, 67, 70). Of the 51 single-
event polymorphisms, 9 are within five ORFs of a transposase
or contain a transposase, indicating that these IS-type elements
have a role in generating C. burnetii genetic diversity. Indeed,
Southern blotting shows a range in the number of IS elements
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between C. burnetii isolate genomic groups (manuscript in
preparation). By this analysis, isolates within a genomic group
have identical hybridization patterns, supporting the phyloge-
netic relationships revealed by CGH. Movement and/or loss of
these mobile elements could be a mechanism by which C.
burnetii rearranges and/or reduces its genome to better suit its
intracellular lifestyle.
In summary, the present study provides the first comprehen-
sive whole-genome genotyping of C. burnetii. We show that, in
general, the genomes of C. burnetii isolates obtained from a
wide range of biologically and geographically diverse sources
are highly conserved. However, notable ORF polymorphisms
occur that may contribute to the virulence potential and other
biological properties of C. burnetii isolates. CGH assessment of
C. burnetii genome content can help to identify cross-protective
subunit vaccine candidates for protection against Q fever and
facilitate the development of new diagnostic tools and, as an
epidemiological method, to classify clinical, forensic, and en-
vironmental isolates. Indeed, in conjunction with whole-ge-
nome amplification, rapid whole-genome typing of isolates in
clinical samples can be achieved without propagation of the
organism. Finally, a CGH approach to identify potential patho-
type-specific virulence genes is especially valuable considering
the lack of genetic systems for C. burnetii.
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